532296:BOM
Glenmark Pharmaceuticals Ltd
2 224,00 ₹
arrow_downward
-1,17%(-26,30) 1D
16 қаз., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
2 249,80 ₹
High
2 264,00 ₹
Low
2 224,00 ₹
Mkt. cap
628,43 млрд
Avg. vol.
17,97 мың
Volume
12,94 мың
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
2025 ж. 03 қаз.
P/E ratio
34,92
52-wk high
2 536,85 ₹
52-wk low
1 794,00 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 мың
Open
2 249,80 ₹
High
2 264,00 ₹
Low
2 224,00 ₹
Mkt. cap
628,43 млрд
Avg. vol.
17,97 мың
Volume
12,94 мың
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
2025 ж. 03 қаз.
P/E ratio
34,92
52-wk high
2 536,85 ₹
52-wk low
1 794,00 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 мың
News stories
From web sources and news partners
Law360
·
58 минут бұрын
Nasdaq Sued Over Delisting Of Social Media Co.
Yahoo Finance
·
34 минут бұрын
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
MarketBeat
·
32 минут бұрын
Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in Stock
Seeking Alpha
·
58 минут бұрын
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd